Strategy to Target Acquired Resistance in MelanomaBrainMets

Strategy to Target Acquired Resistance in MelanomaBrainMets

Torben Redmer (ORCID: 0000-0002-0050-9478)

Disciplines

Biology (10%); Clinical Medicine (50%); Medical-Theoretical Sciences, Pharmacy (40%)

Keywords

    Melanoma, Brain metastasis, Resistence, BRAF inhibition, MET receptor, Pharmacogenomics

Research institution(s)